Clinical research across Eastern Europe
Full-Service Clinical Research Organization in Eastern Europe
Reliable clinical operations, regulatory support and study delivery for global biotechnology, pharmaceutical and medical-device sponsors.
Discuss your study
Regional expertise, sponsor-focused delivery
IRIS CRO is a full-service clinical research organization established by experienced clinical research professionals. We provide client-focused operational support across Latvia, Georgia, Poland, Lithuania and Ukraine for global biotechnology, pharmaceutical, medical-device and cosmetics organizations.
Our multi-country footprint combines local regulatory knowledge, established site relationships and direct communication. Teams support studies across phases I–IV and are selected according to protocol, therapeutic-area and country requirements.
Who we work with
We support pharmaceutical, biotechnology, medical-device and cosmetics organizations across phases I–IV. Detailed capabilities, delivery models and indicative submission timelines are available on the dedicated Services page.
Insights for sponsors
Practical guides on start-up, submissions and country feasibility.
Clinical Trial Start-Up in Eastern Europe: A Sponsor Checklist
A practical checklist for sponsors planning clinical trial start-up in Latvia, Lithuania, Poland, Georgia and Ukraine.
CTIS Submissions in Latvia, Lithuania and Poland: What Sponsors Should Prepare
What sponsors should prepare for Clinical Trials Information System (CTIS) submissions in Latvia, Lithuania and Poland.
How to Run Country Feasibility for a Multi-Country Trial
How sponsors can run country and site feasibility for multi-country clinical trials and compare countries on realistic criteria.
Planning Clinical Trials Outside the EU: Georgia and Ukraine
Planning considerations for clinical trials in Georgia and Ukraine: national procedures, ethics review, investigational product logistics and risk planning.
Countries we support
Choose a country for local clinical-research information.